Before Rectal Cancer Surgery: Four Questions About Japan’s SI-449 Adhesion Study
By Dechuan in Tokyo | JapanMed AI. Published and evidence checked: October 1, 2026. This educational article has not undergone an individual clinical assessment.
Should a new adhesion barrier change where you have surgery?
A report about an adhesion-prevention material is not enough, on its own, to justify travelling to Japan for rectal cancer surgery. First ask whether the study matches the planned operation, which outcome improved, and what the local surgical team already offers. A Japanese expert second opinion can help frame those questions; it cannot determine suitability from a headline.
Families understandably focus on cancer removal and whether a stoma will be needed. A new device adds another decision, but it should be considered within the overall treatment plan, including timing and follow-up after returning home.
What the research actually found
Japan’s National Cancer Center described the SI-449 study on September 29, 2026. The original paper appeared online in JAMA Surgery on August 26. In the randomized study across 53 Japanese hospitals, 131 patients were assigned to groups and 118 underwent the later procedure needed for efficacy assessment. Adhesions beneath the midline incision were found in 45% of the SI-449 group and 93% of the group receiving no additional adhesion-prevention procedure. NCC research summary.
Participants were adults undergoing open rectal resection with a temporary ileostomy and planned subsequent closure. Those details matter. The trial does not establish the same results for every abdominal operation, minimally invasive surgery, or every patient with rectal cancer.
Evidence stage and unresolved questions
Evidence stage: completed randomized clinical trial results concerning a medical device. Seikagaku reports Japanese approval of SI-449 in April 2026. Approval, trial evidence, and availability at a particular hospital are separate issues; this article does not verify hospital supply or individual eligibility. Manufacturer’s regulatory background.
The paper explains that roughly five to six months of follow-up cannot establish long-term reductions in bowel obstruction or chronic pain. The comparison was with no additional barrier procedure, not with other available adhesion-prevention products. It therefore cannot establish superiority over every alternative. Nor did it establish improved cancer survival or reduced recurrence. Original trial.
Four questions for a surgical second opinion
- Does the planned operation match the evidence? Ask why open, laparoscopic or robotic surgery is proposed and whether this particular trial is relevant.
- What takes priority? Ask how adhesion prevention fits within cancer treatment and whether any change would affect the agreed timetable.
- What is already available locally? Request an explanation of current preventive measures, alternatives and reasons a material might be unsuitable.
- Who manages recovery? Clarify stoma care, follow-up and access to urgent assessment. Consider the practical burden of splitting care across countries.
These are discussion prompts, not a standardized list of mandatory investigations. A second opinion is most useful when it answers a defined unresolved question.
Who might benefit—and when waiting is inappropriate
Consider another expert review when important explanations remain unclear or surgical recommendations differ, provided the treating team believes there is time for consultation. A well-explained local plan does not need to be reopened solely because a new material appears in the news.
Abdominal adhesions are scar-like tissue connections. Many cause no symptoms, while some can obstruct the bowel. Significant abdominal pain, distension, vomiting or inability to pass gas or stool calls for prompt local assessment, not a wait for an overseas opinion. NIDDK patient information.
Prepare a focused record set
Start with the treating clinician’s summary, pathology report, original imaging and reports, previous operation notes, treatment timeline, medication list and proposed surgical plan. Include stoma-related records when applicable. Confirm the receiving hospital’s specific document and translation requirements; NCC’s second-opinion service requests clinical information in advance. Hospital service information.
Frequently asked questions
Can SI-449 remove adhesions after surgery?
The reported intervention was applied during surgery. This trial does not establish removal of existing adhesions.
Does less adhesion mean better cancer control?
No cancer-recurrence or survival benefit was established by this study.
Do the results apply to laparoscopic surgery?
The open-surgery results cannot simply be transferred to another technique. Ask for evidence specific to the planned operation.
Does a second opinion require travel to Japan?
Not necessarily. Confirm the hospital’s available consultation formats. A review may also support continuing the existing local plan.
Japan Expert Second Opinion
Begin with one question you want clarified. If seeking a written opinion from a Japanese specialist, confirm that the hospital offers the relevant service, what it costs and which records it requires. Discuss the resulting advice with the local treating team before making changes or travel arrangements.
Risks and limitations
This article supports medical education and decision preparation. It is not a diagnosis, device recommendation or eligibility assessment. Do not post medical records or identity documents in public comments. A second opinion is a decision tool: it does not promise a different treatment plan and does not require travel to Japan.
Primary sources
- National Cancer Center Japan, SI-449 research announcement, September 29, 2026.
- Kanemitsu et al., randomized trial, JAMA Surgery, August 26, 2026. Randomized: 131; efficacy analysis: 118.
- Seikagaku, R&D Basic Policy. Page update date not stated; approval month checked, hospital availability unverified.
- NIDDK, Abdominal Adhesions. Update date not confirmed in the retrieved extract.
- National Cancer Center Hospital, Second Opinion. Update date not confirmed in the retrieved extract.
All sources checked October 1, 2026.
For readers who prefer ongoing Chinese-language education, the optional WeChat reading channel is 德川在东京. This is an educational channel, not an emergency service.